Stockreport

Ikena Oncology Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

Ikena Oncology, Inc.  (IKNA) 
PDF US$1.63 loss per share (improved from US$1.90 loss in FY 2022). IKNA Products In Clinical Trials Phase I: 2. All figures shown in the chart above are for the trai [Read more]